CASI240816C7500
- 0.38
- 0.000.00%
CASI Pharmaceuticals Newsroom
CASI Pharmaceuticals Freezes Juventas Assets Amid Dispute
Express News | CASI Pharmaceuticals Inc - CASI Pharmaceuticals Obtains Asset Freezing Order in Court of P.r. China Against Juventas
CASI Pharmaceuticals Welcomes New CFO
CASI Pharma Taps Athenex's Daniel Lang, MD as CFO
CASI Pharmaceuticals Names Daniel Lang Chief Financial Officer >CASI
Express News | CASI Pharmaceuticals Announces Appointment of Daniel Lang, Md as CFO and Svp
CASI Pharmaceuticals (CASI) Up on Buyout Offer for China Business
Express News | CASI Pharmaceuticals Shares Are Trading Higher After the Company Announced Plans to Submit an Investigational New Drug Application to the FDA for CID-103 for the Treatment of Antibody-mediated Rejection in Kidney Transplant Recipients.
Market-Moving News for June 27th
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data
Top Premarket Gainers
Trending Stocks Today: Assure Shoots up 161.07% Pre-Market
CASI Pharmaceuticals Sees Dramatic After-Hours Surge
Stocks to Watch: Levi Strauss, Casi Pharmaceuticals, Recursion Pharmaceuticals, Aterian
CASI Pharmaceuticals' Shares Rally Following CEO's Offer to Buy China Operations
Trending Stocks Today: CASI Pharmaceuticals Shoots up 69.31% Post-Market
CASI Pharmaceuticals: Committee to Evaluate Other Strategic, Business Alternatives Available in Respect to Business Ops in China >CASI
CASI Pharmaceuticals: Board Has Formed Special Committee of Incumbent Independent Directors to Evaluate Transaction Contemplated >CASI
Express News | CASI Pharmaceuticals Announced Plan To Submit CID-103 IND Application; Also Announces Receipt Of A Non-binding Proposal To Acquire Its China Business For Aggregate Purchase Price Of $40M
Express News | CASI Pharmaceuticals Inc - Proposed Deal for Purchase Price of $40.0 Mln, Which Shall Include Assumption of up to $20.0 Mln of Indebtedness of Company